Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
287 hedge funds and large institutions have $1.3B invested in Avanos Medical in 2023 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 79 increasing their positions, 81 reducing their positions, and 26 closing their positions.
133% more call options, than puts
Call options by funds: $98K | Put options by funds: $42K
27% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 26
19% more capital invested
Capital invested by funds: $1.1B → $1.3B (+$209M)
1.34% more ownership
Funds ownership: 93.22% → 94.55% (+1.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less funds holding
Funds holding: 288 → 287 (-1)
2% less repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 81
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$36M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$10.2M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.19M |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$5.56M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$5.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
-$19.5M |
| 2 |
Goldman Sachs
New York
|
-$11M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$6.47M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.58M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$4.43M |
AVNS Hedge Fund Activity: Q1 2023 in Review
287 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2023, worth a combined $1.3B — up 19% from $1.1B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new AVNS positions and 26 closed out — a net gain of 7 holders — while 79 added to existing stakes and 81 trimmed.
The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $36M. The largest seller was Westwood Holdings Group, cutting an estimated $19.5M.
- 287 institutional investors held Avanos Medical (AVNS) as of Q1 2023, down from 288 in Q4 2022.
- Funds reported $1.3B of Avanos Medical stock for Q1 2023, up 19% quarter-over-quarter.
- 33 funds opened new Avanos Medical positions in Q1 2023 and 26 closed out, a net change of +7 holders.
- The largest Avanos Medical buyer in Q1 2023 was T. Rowe Price Investment Management, an estimated $36M added.
- The largest Avanos Medical seller in Q1 2023 was Westwood Holdings Group, an estimated $19.5M sold.
Based on aggregated 13F filings for Q1 2023.